X0306 4 2015-05-29 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001238403 SPIEGELMAN DANIEL K C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Chief Financial Officer Common Stock 2015-05-29 2015-05-29 4 F 0 4305 125.57 D 37202 D Common Stock 2015-05-29 2015-05-29 4 S 0 1578 126.1502 D 35624 D Common Stock 2015-06-01 2015-06-01 4 S 0 3945 124.16 D 31679 D This transaction, which should have been reported on June 2, 2015, is being reported late due to an administrative oversight. Trade made pursuant to a 10b5-1 plan executed on March 11, 2015. The price in column 4 is a weighted average price. The price actually received ranged from $125.60 to $127.78. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. The price in column 4 is a weighted average price. The price actually received ranged from $123.06.60 to $124.93. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. /s/ Laura Randall Woodhead, Attorney-in-Fact 2015-06-02